Ensar HALILOVIC

City:

Canton, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2023-12-14

Top Assignees for applications by Ensar HALILOVIC

The entities that hold a legal rights for patent applications filed by inventor HALILOVIC Ensar:

NOVARTIS AG 2 Basel, Switzerland
LES LABORATOIRES SERVIER 1 SURESNES CEDEX, France
NOVARTIS AG 1 Basel, France
LES LABORATORIES SERVIER 1 SURESNES, France

Recent patent applications by HALILOVIC Ensar

Ensar HALILOVIC from Canton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-12-14

US20230398115A1

Human necessities

MDM2 INHIBITORS AND COMBINATIONS THEREOF

#2 | 2022-09-08

US20220281970A1

Chemistry; metallurgy

Pharmaceutical Combinations

#3 | 2022-01-20

US20220016118A1

Human necessities

COMBINATION OF A MCL-1 INHIBITOR AND MIDOSTAURIN, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#4 | 2021-12-16

US20210386763A1

Human necessities

PHARMACEUTICAL COMBINATIONS

#5 | 2021-11-25

US20210363254A1

Chemistry; metallurgy

PHARMACEUTICAL COMBINATIONS

#6 | 2021-08-26

US20210260059A1

Human necessities

MDM2 INHIBITORS AND COMBINATIONS THEREOF

#7 | 2020-09-10

US20200281910A1

Human necessities

Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers

#8 | 2019-11-07

US20190336505A1

Human necessities

Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof

#9 | 2019-08-08

US20190240225A1

Human necessities

COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

InventorID:

2578433 ⎘